Ketorolac Eye Drops Are NOT Appropriate for Herpes Zoster Ophthalmicus
Ketorolac eye drops should NOT be used for herpes zoster ophthalmicus (HZO) as they do not address the underlying viral infection and provide no therapeutic benefit for this condition. The cornerstone of HZO treatment is systemic antiviral therapy, not topical NSAIDs like ketorolac.
Primary Treatment: Oral Antivirals
The 2024 Conjunctivitis Preferred Practice Pattern guidelines clearly establish that oral antivirals are the mainstay of treatment for varicella zoster virus (VZV) conjunctivitis and HZO 1. The recommended regimens for immunocompetent patients with persistent or recalcitrant acute/subacute disease are:
- Acyclovir 800 mg five times daily for 7 days
- Valacyclovir 1000 mg every 8 hours for 7 days
- Famciclovir 500 mg three times daily for 7 days
These antivirals are most effective when initiated within 72 hours of rash onset 2. A 2025 randomized clinical trial demonstrated that suppressive valacyclovir treatment (1000 mg daily for 12 months) reduced multiple episodes of keratitis or iritis at both 12 and 18 months 3.
Why Ketorolac Is Not Indicated
Ketorolac is an NSAID indicated only for:
- Ocular itching due to seasonal allergic conjunctivitis
- Postoperative inflammation after cataract extraction 4
The FDA label makes no mention of viral infections, and ketorolac has no antiviral properties. While one study showed ketorolac reduced pain in corneal abrasions 5, this is fundamentally different from treating a viral infection like HZO.
What About Topical Antivirals?
The guidelines explicitly state that topical antivirals alone have not been shown to be helpful in treating VZV conjunctivitis but may be used as additive treatment in unresponsive patients 1. This further underscores that topical therapy (whether antiviral or NSAID) is insufficient for HZO.
Adjunctive Treatments
Topical antibiotics are often prescribed to prevent secondary bacterial infection, as vesicles undergo necrosis before healing and severe conjunctival scarring can lead to cicatricial ectropion 1.
Topical corticosteroids may be considered for inflammatory complications (keratitis, uveitis) but only under ophthalmologic supervision, as they can worsen epithelial viral infections 1.
Critical Pitfalls to Avoid
- Do not delay systemic antiviral therapy while attempting symptomatic treatment with ketorolac
- Do not confuse HZO with post-cataract inflammation (where ketorolac IS indicated)
- Urgent ophthalmology consultation is required for any suspected ocular involvement, as up to 50% of HZO patients develop ocular disease and 25% develop chronic/recurrent disease 6
- Patients with uncontrolled diabetes or immunosuppression require particularly careful monitoring for recurrence 7
Bottom Line
Use oral antivirals (valacyclovir, acyclovir, or famciclovir) as first-line treatment for HZO, not ketorolac eye drops. Ketorolac has no role in treating the viral infection itself and should not be substituted for appropriate antiviral therapy. If pain control is needed, systemic analgesics are more appropriate than relying on a topical NSAID that won't address the underlying pathology.